Participating in research provides patients with access to cutting-edge treatments and benefit the population and the health services as a whole by leading to the development of more effective, high quality, cost-efficient treatments and healthcare delivery models. ERNs represent an unicum in the clinical and research worldwide collaborative panorama, indeed 24 ERNs span the over 6000 rare diseases by involving 300 EU HCPs and over 1000 specialized units in 25 EU countries
View this resource Bookmark this resource
European Reference Networks
Published by IRDiRC
Research and Drug DevelopmentNetworkRare DiseaseEuropean Reference NetworkClinical CollaborationResearch Collaboration